BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 20188831)

  • 1. Dehydroepiandrosterone to induce murine models for the study of polycystic ovary syndrome.
    Motta AB
    J Steroid Biochem Mol Biol; 2010 Apr; 119(3-5):105-11. PubMed ID: 20188831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of metformin in the treatment of polycystic ovary syndrome (PCOS).
    Wang HS
    Chang Gung Med J; 2006; 29(5):445-7. PubMed ID: 17214387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin and oral antidiabetic agents for treatment of polycystic ovary syndrome.
    Kuscu NK; Koyuncu FM
    Medscape Womens Health; 2002; 7(5):3. PubMed ID: 12466732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mechanisms involved in the action of metformin in regulating ovarian function in hyperandrogenized mice.
    Elia E; Sander V; Luchetti CG; Solano ME; Di Girolamo G; Gonzalez C; Motta AB
    Mol Hum Reprod; 2006 Aug; 12(8):475-81. PubMed ID: 16809378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin in the treatment of polycystic ovary syndrome.
    Motta DA
    Curr Pharm Des; 2008; 14(21):2121-5. PubMed ID: 18691121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory cytokines and chemokines, skeletal muscle and polycystic ovary syndrome: effects of pioglitazone and metformin treatment.
    Ciaraldi TP; Aroda V; Mudaliar SR; Henry RR
    Metabolism; 2013 Nov; 62(11):1587-96. PubMed ID: 23958241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dehydroepiandrosterone induces ovarian and uterine hyperfibrosis in female rats.
    Zhang X; Zhang C; Shen S; Xia Yj; Yi L; Gao Q; Wang Y
    Hum Reprod; 2013 Nov; 28(11):3074-85. PubMed ID: 23980058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic and local effects of metformin administration in patients with polycystic ovary syndrome (PCOS): relationship to the ovulatory response.
    Palomba S; Falbo A; Russo T; Orio F; Tolino A; Zullo F
    Hum Reprod; 2010 Apr; 25(4):1005-13. PubMed ID: 20106839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms involved in metformin action in the treatment of polycystic ovary syndrome.
    Motta AB
    Curr Pharm Des; 2009; 15(26):3074-7. PubMed ID: 19754381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the N, N'-dimethylbiguanide metformin in the treatment of female prepuberal BALB/c mice hyperandrogenized with dehydroepiandrosterone.
    Sander V; Luchetti CG; Solano ME; Elia E; Di Girolamo G; Gonzalez C; Motta AB
    Reproduction; 2006 Mar; 131(3):591-602. PubMed ID: 16514202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin therapy in the management of polycystic ovary syndrome: endocrine, metabolic and reproductive effects.
    Nardo LG; Rai R
    Gynecol Endocrinol; 2001 Oct; 15(5):373-80. PubMed ID: 11727360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The management of insulin resistance in polycystic ovary syndrome.
    Teede HJ; Hutchison SK; Zoungas S
    Trends Endocrinol Metab; 2007 Sep; 18(7):273-9. PubMed ID: 17698366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-sensitizing agents in the treatment of polycystic ovary syndrome: an update.
    Katsiki N; Hatzitolios AI
    Curr Opin Obstet Gynecol; 2010 Dec; 22(6):466-76. PubMed ID: 20724929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin effects on clomifene-induced ovulation in the polycystic ovary syndrome.
    Ben Ayed B; Dammak dit Mlik S; Ben Arab H; Trabelssi H; Chahtour H; Mathlouthi N; Dhuib M; Kassis M; Saiidane D; Trabelssi K; Guermazi M
    Tunis Med; 2009 Jan; 87(1):43-9. PubMed ID: 19522426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin in polycystic ovary syndrome.
    Diamanti-Kandarakis E; Economou F; Palimeri S; Christakou C
    Ann N Y Acad Sci; 2010 Sep; 1205():192-8. PubMed ID: 20840272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin regulates ovarian angiogenesis and follicular development in a female polycystic ovary syndrome rat model.
    Di Pietro M; Parborell F; Irusta G; Pascuali N; Bas D; Bianchi MS; Tesone M; Abramovich D
    Endocrinology; 2015 Apr; 156(4):1453-63. PubMed ID: 25590243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of metformin on insulin resistance, androgen concentration, ovulation and pregnancy rates in women with polycystic ovary syndrome following laparoscopic ovarian drilling.
    Kocak I; Ustün C
    J Obstet Gynaecol Res; 2006 Jun; 32(3):292-8. PubMed ID: 16764619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-lowering agents inhibit synthesis of testosterone in ovaries of DHEA-induced PCOS rats.
    Misugi T; Ozaki K; El Beltagy K; Tokuyama O; Honda K; Ishiko O
    Gynecol Obstet Invest; 2006; 61(4):208-15. PubMed ID: 16479139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocimum kilimandscharicum L. restores ovarian functions in letrozole - induced Polycystic Ovary Syndrome (PCOS) in rats: Comparison with metformin.
    Khaled N; El-Bahy AA; Radwan R; Handoussa H; AbdelMaksoud S
    Life Sci; 2019 Sep; 232():116640. PubMed ID: 31295470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of metformin in patients with polycystic ovary syndrome: the state of the art.
    Palomba S; Falbo A; Russo T; Orio F; Tollino A; Zullo F
    Minerva Ginecol; 2008 Feb; 60(1):77-82. PubMed ID: 18277354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.